Who are they? And what did/do they know re $TSOI SEC filings? $TSOI #UofM #Millerschool #thecurealliance #Ricordi #Kenyon #Lanzoni #FDA #NIH https://t.co/XIIHFrEiv3 https://t.co/b1ovuqWtAm https://t.co/Z5earXVsPa https://t.co/mhDV6hhUEw https://t.co/
@GroteOdie @rrao111 @TSOIsupplement @CampbellNeuros1 @exosome Let’s start by reviewing the lead author on the P2 trial/paper wherein $TSOI claims shenanigans Giancomo Lanzoni, Research Assistant Professor, Diabetes Research Institute & BMB Dpt, Univer
@moneymansob @RWyoral I never said they failed a phase 1 i said they never did one, did they ? How i am i in question ? Our phase 1 is published https://t.co/Pd01Ej6gUp
@HunterCollins32 No, like the phase III clinical trial trying to get people off ventilators with our adult stem cell. This is based on our previous study https://t.co/wlJ6lOqBlr
RT @exosome: This is the peer-reviewed paper describing the efficacy of the #jadicell stem cell in a double blind #clinicaltrial. We at $T…
RT @thommic: $tsoi
$tsoi
RT @exosome: This is the peer-reviewed paper describing the efficacy of the #jadicell stem cell in a double blind #clinicaltrial. We at $T…
RT @exosome: This is the peer-reviewed paper describing the efficacy of the #jadicell stem cell in a double blind #clinicaltrial. We at $T…
This is the peer-reviewed paper describing the efficacy of the #jadicell stem cell in a double blind #clinicaltrial. We at $TSOI has launched a Phase III clinical trial for #covid19, we obtained an IND number for CTE and have filed an IND for #COPD ht
I find all of this interesting and ties to $TSOI have to read and re read https://t.co/dDVxoPlljn https://t.co/huewpfPZHI https://t.co/fwSoSF0e4s https://t.co/XD5G9ROjY5 https://t.co/rhEERjc0Hh
If the world put 1% of the energy and visibility put on $GME and $AMC on $TSOI could you imagine the progress and lives that could be saved?
@orlandostockey @chyeeahhh https://t.co/YLx94RxmAL https://t.co/DurcdRKFYE Hope this helps. $tsoi
RT @Tricksare4kids2: This is a document released earlier this year, but for anyone wanting to read the FULL study and gain your own opinion…
This is a document released earlier this year, but for anyone wanting to read the FULL study and gain your own opinion of $TSOI this is quite valuable https://t.co/Diy6WnnVFL
RT @rrao111: $TSOI - Getting ready to help people with COVID Lung damage across the world! https://t.co/ajGCLPPKAH @TSOIsupplement @Cam…
$TSOI - Getting ready to help people with COVID Lung damage across the world! https://t.co/ajGCLPPKAH @TSOIsupplement @CampbellNeuros1
Using mesenchymal stem cells to treat ARDS - which is INCREDIBLE! https://t.co/Dwk9qT670D
Mesenchymal Stem Cell therapy has continued to demonstrate great efficacy against #covid19 ever since the pandemic began. Looking forward to following this great work in Phase 3 Clinical Trials & its application to other inflammatory and immune conditi
Umbilical cord mesenchymal stem cells for COVID‐19 acute respiratory distress syndrome: A double‐blind, phase 1/2a, randomized controlled trial - Lanzoni - 2021 - STEM CELLS Translational Medicine - Wiley Online Library TSOI has a great potential future💰 h
@JonyBalogna @LitaTweets @anne_lacava https://t.co/iAqlnOP0dq The second link is just for treatment. Understand, I have no problem with it whatsoever. https://t.co/ftqjOrBMip
Ensayo doble ciego en pacientes #COVID19 en VMI o VMNI (Abril a julio de 2020, Miami) con células mesenquimales procedentes de cordón umbilical, 24 pacientes, 1:1 https://t.co/bqSggScd1k Mortalidad grupo placebo 7/12 (58%), grupo con células mesenquimales
@Smartitina esempio di cura dimostratasi efficace (in un trial di fase 1/2a): https://t.co/b87Va0c0Ax cellule staminali mesenchimali tratte da cordone ombelicale. Dal lavoro pubblicato si è dimostrata mortalità azzerata, infatti è partita da mesi la sperim
Great to see @univmiami's clinical trial published. #MSC therapy resulted in a 91% patient survival with a significant decrease in #inflammatory #cytokinelevels without serious adverse events in #COVID19 patients. Looking forward to seeing next steps. ht
RT @StemCellsTM: Umbilical cord mesenchymal stem cells for COVID‐19 acute respiratory distress syndrome: A double‐blind, phase 1/2a, random…
Umbilical cord mesenchymal stem cells for COVID‐19 acute respiratory distress syndrome: A double‐blind, phase 1/2a, randomized controlled trial #CellTransplantation #CellularTherapy #ClinicalTrials ##MSC #RespiratoryTract #Transplantation #UmbilicalCord h
US researchers report Umbilical cord-derived mesenchymal stem cells to be effective in the treatment of #COVID lung disorder (#ARDS) in a double-blind, phase 1/2a, randomized, controlled trial. For more details, https://t.co/weBeasztZU #covid19research #
How different is $LGVN study from this? https://t.co/p9IKoic7TK
RT @rrao111: $TSOI -waiting for FDA Ph3 initiation approval https://t.co/zRGAynKmxY https://t.co/wf2TpnbiTS @TaylorB16445829 @rajupenu @…
RT @rrao111: $TSOI -waiting for FDA Ph3 initiation approval https://t.co/zRGAynKmxY https://t.co/wf2TpnbiTS @TaylorB16445829 @rajupenu @…
$TSOI -waiting for FDA Ph3 initiation approval https://t.co/zRGAynKmxY https://t.co/wf2TpnbiTS @TaylorB16445829 @rajupenu @TSOIsupplement @foundmyfitness @CampbellNeuros1 @AusStemCell @ATStemCell @stemcellnews @StemCellMarket @CellStemCell @LillyPad @Li
@foundmyfitness -I recently saw your YouTube video reg. COV related lung damage! Recent PR by @TSOIsupplement - $TSOI reg. Acquisition of & awaiting FDA approval to initiate Ph.3 with COV-SARS rel. Lung Damage w/ 91% success rate. https://t.co/wf2Tpns
@CiccioIlBrillo @GiCagnassola @RobertoBurioni https://t.co/b87Va0c0Ax Questo è invece un esempio SERIO di come una cura contro Covid-19, in questo caso a base di UC-MSCs (cellule staminali mesenchimali da cordone ombelicale) possa essere provata nella sua
@neilriordan this trial happened in Miami? Can you do UC-MSC treatments in the US or Canada now?
@utzpaolo @MissPanix14 @GiovanniToti e 47 mila citazioni non ha bisogno di riflettori mediatici, e in questi mesi al posto di fare proclami in tv ha lavorato e portato a casa una terapia strabiliante -> https://t.co/b87Va0c0Ax, i cui trials di fase 2/3
@otonashi_samm @hgggggiu1 @sgoiufficiale @gbdeclaration (UC-MSCs = infusione di staminali mesenchimali da cordone ombelicale, 100% di efficacia nei soggetti in t.i. under 85 e 91% negli over 85, trial fase 1/2a https://t.co/b87Va0c0Ax)
Top Ranking 4 Stem Cells for COVID-19 Most patients we saved had Diabetes. This will help tremendously the cure of T1D and other autoimmune diseases. https://t.co/Ju4jf4LQoM #top #TopRanking #stemcell #stemcelltherapy #COVID19 #diabetes #diabetestype1
@getagrip1986 @LMTLMTLMT @Dwellewd1 @GovernorsOffice @GovernorTomWolf @pahealthsec Sorry you’re claiming that insurance companies have been seeing medical fraud on a massive scale? With absolutely no evidence? Covid care is not general, it’s actually prett
RT @StemCellsTM: Umbilical cord mesenchymal stem cells for COVID‐19 acute respiratory distress syndrome: A double‐blind, phase 1/2a, random…
@KimmelmanJ There do seem to be tradeoffs. I also wonder about a paper like this (https://t.co/6Sd4HwyNug) where they included placebo & claim efficacy, but the study was so small & somewhat unbalanced in group characteristics that I don't see how
Umbilical cord mesenchymal stem cells for COVID‐19 acute respiratory distress syndrome: A double‐blind, phase 1/2a, randomized controlled trial https://t.co/mc4JjrIcCy https://t.co/7XW7vNM6XK
RT @StemCellsTM: Umbilical cord mesenchymal stem cells for COVID‐19 acute respiratory distress syndrome: A double‐blind, phase 1/2a, random…
Umbilical cord mesenchymal stem cells for COVID‐19 acute respiratory distress syndrome: A double‐blind, phase 1/2a, randomized controlled trial #celltransplantation #cellulartherapy #clinicaltrials #MSC #umbilicalcord #COVID19 #ARDS https://t.co/mc4JjrIcC
Might stem cells be effective at treating severe #COVID19 #ARDS? We need more and larger studies, but this small study suggests they could have a benefit https://t.co/O44734V8oz
Umbilical cord mesenchymal stem cells for COVID-19 acute respiratory distress syndrome: A double-blind, phase 1/2a, randomized controlled trial. Giacomo Lanzoni et al. Stem Cells Transl Med . 2021 Jan 5 https://t.co/ApMy4dlbDg possible breakthrough in smal
Las células del cordón reparan los daños en pacientes #COVID19 >> Link al estudio clinico: https://t.co/nFXRv4UZGx #clinicaltrials #stemcells #celulasmadre #salud #covid #avance #medicina https://t.co/HWTGXEqLQb
RT @Cord_Blood_News: Researchers investigated the treatment of #UmbilicalCord MSCs in the treatment of #COVID-19 acute respiratory distress…
RT @Cord_Blood_News: Researchers investigated the treatment of #UmbilicalCord MSCs in the treatment of #COVID-19 acute respiratory distress…
Il cordone ombelicale ritorna utile per questa nostra rinascita #staminali #cura #covid https://t.co/LuSNGigsPp
🔵Celulas madre mesenquimales de cordon umbilical para el SARS2CoV19: ensayo controlado aleatorio doble ciego. Umbilical cord mesenchymal stem cells for COVID‐19 acute respiratory distress syndrome: A double‐blind, phase 1/2a, randomized controlled trial
///// https://t.co/aV5JdZ42Da
Umbilical cord mesenchymal stem cells for COVID‐19 acute respiratory distress syndrome: A double‐blind, phase 1/2a, randomized controlled trial https://t.co/MmlT4GM7Wt
The results of this trial indicate that UC‐MSC infusions in COVID‐19 with ARDS are safe. Moreover, UC‐MSC treatment was associated with a significant reduction in SAEs, mortality, and time to recovery, compared with controls. https://t.co/sTwlacslcU
The results of this trial indicate that UC‐MSC infusions in COVID‐19 with ARDS are safe. Moreover, UC‐MSC treatment was associated with a significant reduction in SAEs, mortality, and time to recovery, compared with controls. https://t.co/5DYAA8KPHz
The results of this trial indicate that UC‐MSC infusions in COVID‐19 with ARDS are safe. Moreover, UC‐MSC treatment was associated with a significant reduction in SAEs, mortality, and time to recovery, compared with controls. https://t.co/T4X8cUhsfB
The results of this trial indicate that UC‐MSC infusions in COVID‐19 with ARDS are safe. Moreover, UC‐MSC treatment was associated with a significant reduction in SAEs, mortality, and time to recovery, compared with controls. https://t.co/aDbnRWSgbf
Umbilical cord mesenchymal stem cells for COVID‐19 acute respiratory distress syndrome: A double‐blind, phase 1/2a, randomized controlled trial - Lanzoni - - STEM CELLS Translational Medicine - Wiley Online Library Buying CELZ is going to make you rich soo
RT @PublicCBBC: 📌The year seems to have made a promising start! Read about how #umbilical-cord derived #MSCs assist in recovery from sever…
Here is the actual scientific publication. Open access. Thank God. https://t.co/JOJCQHD50h
😷 Double Blind Umbilical cord mesenchymal stem cells for COVID19 ARDS. Promising study in a challenging situation. 24 randomized adult subjects Survival 91%vs 42%. @karisma_IDRx @adass_pedsID @KsenyaShli @ https://t.co/OCCA5uLuMQ.
RT @Cord_Blood_News: Researchers investigated the treatment of #UmbilicalCord MSCs in the treatment of #COVID-19 acute respiratory distress…
RT @YLeyfman: Promising early phase clinical study from @univmiami reaffirming the potential of mesenchymal #stemcells & their efficacy in…
Promising early phase clinical study from @univmiami reaffirming the potential of mesenchymal #stemcells & their efficacy in #COVID19. #SARSCoV2 #SARS_CoV_2 #COVID #COVID20 #coronavirus #CoronavirusStrain #CoronaVirusUpdates @UMiamiHealth https://t.c
Un estudio espectacular. Células madre mesenquimales para COVID 19. https://t.co/2OIj7BGfsx
Researchers investigated the treatment of #UmbilicalCord MSCs in the treatment of #COVID-19 acute respiratory distress syndrome 🫁 through a double-blind Phase Ia/IIa controlled trial. https://t.co/FAn8rcF2iP https://t.co/Rcm7h5Vn1a
Umbilical cord mesenchymal stem cells for COVID‐19 acute respiratory distress syndrome: A double‐blind, phase 1/2a, randomized controlled trial - Lanzoni - - STEM CELLS Translational Medicine - Wiley Online Library https://t.co/AUDNsFXvfi
Ensayo Clínico Fase I y IIa. Uso de células madre mesenquimales de cordón umbilical en pacientes con COVID19. Genera un 91% de supervivencia en pacientes hospitalizados y disminuyen significativamente los niveles séricos de citoquinas. https://t.co/JRIyOq
Umbilical cord mesenchymal stem cells for COVID‐19 acute respiratory distress syndrome: A double‐blind, phase 1/2a, randomized controlled trial https://t.co/wpQIOmv0mr
#CoronavirusGoodNews (4/4): See also: "Umbilical cord mesenchymal stem cells for COVID‐19 acute respiratory distress syndrome: A double‐blind, phase 1/2a, randomized controlled trial" By Camillo Ricordi et al. https://t.co/KuEel8FnmU
#COVID19 Treatment Umbilical cord mesenchymal stem cells therapy was associated with significantly improved patient survival (91% vs 42%). Total 12 patients treated but at least an RCT. Can this be replicated in larger studies? Scalable? Inexpensive? https
@Nadardemuertito @FierroGossman y por fortuna, como ya es costumbre, está como libre acceso.... https://t.co/xwJ7yKEYAb
RT @SanchezGuijoF: Primer ensayo clínico doble ciego aleatorizado que muestra ventaja significativa (en supervivencia, tiempo de recuperaci…
RT @SanchezGuijoF: Primer ensayo clínico doble ciego aleatorizado que muestra ventaja significativa (en supervivencia, tiempo de recuperaci…
RT @PublicCBBC: 📌The year seems to have made a promising start! Read about how #umbilical-cord derived #MSCs assist in recovery from sever…
RT @PublicCBBC: 📌The year seems to have made a promising start! Read about how #umbilical-cord derived #MSCs assist in recovery from sever…
📌The year seems to have made a promising start! Read about how #umbilical-cord derived #MSCs assist in recovery from severe #COVID19 #cordblood #SaveTheCord #StemCells #hematology #MedTwitter Full article available @StemCellsTM https://t.co/p7kH4uPX4W
RT @SanchezGuijoF: Primer ensayo clínico doble ciego aleatorizado que muestra ventaja significativa (en supervivencia, tiempo de recuperaci…
Umbilical cord mesenchymal stem cells for COVID‐19 acute respiratory distress syndrome: A double‐blind, phase 1/2a, randomized controlled trial https://t.co/awHbEKvEWk
RT @GarciaVictor_: Le lien vers l'étude se trouve ici : https://t.co/7ySmZinZ6c (ou là : https://t.co/Ld3btl4ZH0)
RT @SanchezGuijoF: Primer ensayo clínico doble ciego aleatorizado que muestra ventaja significativa (en supervivencia, tiempo de recuperaci…
RT @SanchezGuijoF: Primer ensayo clínico doble ciego aleatorizado que muestra ventaja significativa (en supervivencia, tiempo de recuperaci…
Why is the #LameStreamMedia hiding the fact that advanced #covid19 can be cured by adult stem cells? #jadicell #jadicells #SARSCoV2 https://t.co/sVNUgoVwA1
@GarciaOlmoD @marianog65 @FelipeProsper @MiriamLopzParra @jmoraledajimnez
RT @SanchezGuijoF: Primer ensayo clínico doble ciego aleatorizado que muestra ventaja significativa (en supervivencia, tiempo de recuperaci…
RT @SanchezGuijoF: Primer ensayo clínico doble ciego aleatorizado que muestra ventaja significativa (en supervivencia, tiempo de recuperaci…
RT @SanchezGuijoF: Primer ensayo clínico doble ciego aleatorizado que muestra ventaja significativa (en supervivencia, tiempo de recuperaci…
Primer ensayo clínico doble ciego aleatorizado que muestra ventaja significativa (en supervivencia, tiempo de recuperación y reducción de citocinas inflamatorias) de las células mesenquimales en pacientes graves con COVID-19 se publica hoy en https://t.co/
Le lien vers l'étude se trouve ici : https://t.co/7ySmZinZ6c (ou là : https://t.co/Ld3btl4ZH0)